Fulcrum Therapeutics, Inc.

NASDAQ:FULC

Biotechnology

Healthcare
$3.72 +1.71%

+$0.06 today

Market cap
$284.14M
Beta
2.92
P/E (TTM)
-3.6
EPS (TTM)
-$1.00
52W Low $2.83High $15.74

Volume 0.63M

Average 1.78M

Price history

Fulcrum Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-61.77%

Period high

$14.60

Period low

$3.14

Latest

$3.72

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
SC 13G/ANov 13, 2026Nov 13, 2026
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
425Nov 12, 2026Nov 12, 2026
424B3Nov 4, 2026Nov 4, 2026
EFFECTNov 4, 2026Nov 5, 2026
S-4/ANov 3, 2026Nov 3, 2026
SC 13G/AOct 28, 2026Oct 28, 2026
SC 13G/AOct 27, 2026Oct 27, 2026
S-4/AOct 20, 2026Oct 20, 2026
S-4/AOct 8, 2026Oct 8, 2026
S-4Sep 2, 2026Sep 1, 2026
425Aug 17, 2026Aug 17, 2026
425Aug 17, 2026Aug 17, 2026

Competitors

Who does Fulcrum Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about FULC's filings, answered from its disclosures.

What is the latest FULC filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does FULC have?

Intrinsic Alpha currently shows 20 recent filings for FULC.